Recombinant Human RLN2 Protein，His

Recombinant RLN2 (Relaxin 2) is a peptide hormone that belongs to the relaxin family, playing a crucial role in various physiological processes, including reproductive functions and cardiovascular regulation. Historically, research on RLN2 has focused on its involvement in pregnancy, where it is produced by the corpus luteum and is thought to facilitate uterine remodeling, cervical softening, and angiogenesis. Beyond its reproductive implications, emerging studies have revealed that RLN2 may exhibit therapeutic potential in the treatment of various cardiovascular diseases by promoting vasodilation and inhibiting fibrosis. Additionally, RLN2 is being explored for its roles in metabolic regulation, neuroprotection, and modulating inflammation, making it a target of interest in multiple biomedical research areas. The advent of recombinant technology allows for the efficient production of RLN2, enabling further exploration of its molecular mechanisms, signaling pathways, and therapeutic applications. Current studies are investigating the optimal delivery methods and formulations of RLN2 to maximize its biological activity and therapeutic effectiveness. As our understanding of RLN2 expands, it holds promise for innovative treatments for conditions such as heart failure, diabetes, and other disorders linked to its regulatory functions.